News and Events

Keep up-to-date on the latest media coverage and events for Intragel

Intragel Announces Expansion of its Head and Neck Cancer Trial to Samson Assuta Ashdod University Hospital in Israel

Intragel Announces Expansion of its Head and Neck Cancer Trial to Samson Assuta Ashdod University Hospital in Israel

With promising results from our first patient treated in Hadassah Ein Kerem Medical Center in Israel, the study will evaluate the safety and effectiveness of a single injection of our flagship Cisplatin-loaded gel, TumoCure, to treat progressive tumors, or those inoperable or resistant to radiotherapy and chemotherapy.

Our gel-based drug delivery product is injected directly into the tumor, using common syringe-needle injection methods, where the drug is slowly released to shrink the tumor with minimal if at all, side effects. We are looking forward to a great partnership.